Forrest General Respiratory Care to Evaluate New Technology
Forrest General Hospital's Respiratory Care Department was the first hospital in the United States selected to evaluate an improved breath-actuated technology. Monaghan Medical selected Forrest General as a testing site to get critical feedback before full launch of this new, market-approved device. Forrest General was one of the first hospitals in the nation to adopt breath-actuated technology when it was first introduced in 2001.
Forrest General Respiratory Care evaluated the next generation AeroEclipse® II breath-actuated nebulizer (AEII™ BAN), a device for delivering medical aerosols to patients. The device enables caregivers to provide fast and accurate patient dosing, as compared to conventional small-volume nebulizers. Additionally, the AE™ II Breath-Actuated Nebulizer emits a comparatively smaller amount of the drug to the environment surrounding the patient during administration, which is of great significance to respiratory care practitioners and other caregivers subject to secondhand exposure.
Tags:None
| 
Digg
Facebook
Technorati
Newsvine
Google
